BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART
Recruiting now
Conditions studied: Breast Cancer, Radiotherapy
In brief
The BRAVE-HEART trial is an ambispective, observational, non-randomized study conducted at Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Policlinico San Matteo (Pavia, Italy). It aims to document and quantify the cardiac dose reduction achievable with breast radiotherapy performed in Deep Inspiration Breath Hold (DIBH) using the Active Breathing Coordinator (ABC) system. Dosimetric parameters from DIBH treatments are evaluated, with free-breathing treatment plans and data from patients treated under free-breathing conditions used as reference. Secondary analyses include treatment reproducibility, comparison of radiotherapy techniques and fractionation schedules, impact of the simultaneous integrated boost (SIB), and assessment of acute and late toxicity during follow-up.
Key facts
- Study ID
- NCT07299812
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
- People needed
- 400
- Starts
- 2024-05-23
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2025-12-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of stage I-III breast carcinoma with an indication for radiotherapy
- Invasive carcinoma or ductal carcinoma in situ (DCIS)
- Radiotherapy delivered using three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated/volumetric modulated arc therapy (IMRT/VMAT) techniques
- Ability to actively cooperate in using the Active Breathing Coordinator (ABC) system for Deep Inspiration Breath Hold (DIBH), or treated under free-breathing conditions when DIBH is not feasible
- Age ≥18 years
- Ability to provide written informed consent for the anonymous use of data for research purposes
You may not qualify if…
- Severe health problems or profound hearing loss
- Severe respiratory or cardiovascular conditions in the medical history that contraindicate radiotherapy
- Inability to provide written informed consent for the anonymous use of data for research purposes
- Absolute contraindications to radiotherapy (e.g., pregnancy, or inability to maintain the correct treatment position)
Where it is running
- Fondazione IRCCS Policlinico San Matteo — Pavia, Lombardy, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.